|
1
|
Lazarus JV, White TM, Wyka K, Ratzan SC, Rabin K, Larson HJ, Martinon-Torres F, Kuchar E, Abdool Karim SS, Giles-Vernick T, Müller S, Batista C, Myburgh N, Kampmann B, El-Mohandes A. Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023. Nat Med 2024; 30:1559-1563. [PMID: 38684861 PMCID: PMC11186753 DOI: 10.1038/s41591-024-02939-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Accepted: 03/21/2024] [Indexed: 05/02/2024]
Abstract
It is unclear how great a challenge pandemic and vaccine fatigue present to public health. We assessed perspectives on coronavirus disease 2019 (COVID-19) and routine immunization as well as trust in pandemic information sources and future pandemic preparedness in a survey of 23,000 adults in 23 countries in October 2023. The participants reported a lower intent to get a COVID-19 booster vaccine in 2023 (71.6%), compared with 2022 (87.9%). A total of 60.8% expressed being more willing to get vaccinated for diseases other than COVID-19 as a result of their experience during the pandemic, while 23.1% reported being less willing. Trust in 11 selected sources of vaccine information each averaged less than 7 on a 10-point scale with one's own doctor or nurse and the World Health Organization, averaging a 6.9 and 6.5, respectively. Our findings emphasize that vaccine hesitancy and trust challenges remain for public health practitioners, underscoring the need for targeted, culturally sensitive health communication strategies.
Collapse
Grants
- Study funding was provided by Moderna, Inc., to the City University of New York (CUNY) Research Foundation. Authors retained full autonomy in the design of the study; the development of the survey instrument; the collection, analysis, and interpretation of data; the presentation of results; and the decision to submit the article for publication. JVL has received speaker fees from Echosens, Gilead Sciences, Moderna, Novo Nordisk, Novovax, Pfizer and ViiV, and grants from Gilead Sciences, GSK, Madrigal Pharmaceuticals, and Roche Diagnostics, outside the submitted work. All other authors declare no competing interests.
Collapse
Affiliation(s)
- Jeffrey V Lazarus
- Graduate School of Public Health and Health Policy, City University of New York, New York City, NY, USA.
- Barcelona Institute for Global Health, Barcelona, Spain.
- Hospital Clínic, University of Barcelona, Barcelona, Spain.
| | - Trenton M White
- Graduate School of Public Health and Health Policy, City University of New York, New York City, NY, USA
- Barcelona Institute for Global Health, Barcelona, Spain
| | - Katarzyna Wyka
- Graduate School of Public Health and Health Policy, City University of New York, New York City, NY, USA
| | - Scott C Ratzan
- Graduate School of Public Health and Health Policy, City University of New York, New York City, NY, USA
| | - Kenneth Rabin
- Graduate School of Public Health and Health Policy, City University of New York, New York City, NY, USA
| | - Heidi J Larson
- London School of Hygiene and Tropical Medicine, London, UK
- Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
| | - Federico Martinon-Torres
- University Clinic Hospital of Santiago de Compostela, Healthcare Research Institute of Santiago (IDIS), Santiago de Compostela, Spain
| | - Ernest Kuchar
- Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland
| | - Salim S Abdool Karim
- Centre for the AIDS Program of Research in South Africa, Durban, South Africa
- Mailman School of Public Health, Columbia University, New York City, NY, USA
| | - Tamara Giles-Vernick
- Anthropology and Ecology of Disease Emergence Unit, Institut Pasteur, Université Paris Cité, Paris, France
| | - Selina Müller
- Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany
| | - Carolina Batista
- Baraka Impact Finance, Geneva, Switzerland
- Movement Health Foundation, Rio de Janeiro, Brazil
| | | | | | - Ayman El-Mohandes
- Graduate School of Public Health and Health Policy, City University of New York, New York City, NY, USA
| |
Collapse
|
|
2
|
Blanchard-Rohner G, Sanchez C, Andre MC, Bressieux-Degueldre S, Grazioli S, Perez MH, Wütz D, Schöbi N, Welzel T, Atkinson A, Schlapbach LJ, Bielicki JA, Trück J. COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children. Pediatr Infect Dis J 2024; 43:361-364. [PMID: 38241661 PMCID: PMC10919269 DOI: 10.1097/inf.0000000000004206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/10/2023] [Indexed: 01/21/2024]
Abstract
Data on COVID-19 vaccine acceptability among parents of children with multisystem inflammatory syndrome (MIS-C) are limited. In this cohort of children with MIS-C, enrolled in the Swissped RECOVERY trial (NCT04826588), comparing intravenous immunoglobulins or methylprednisolone, who, in accordance with Swiss guidelines, were recommended for SARS-CoV-2 vaccination, 65% (73/112) of parents reported being vaccinated against SARS-CoV-2 before the MIS-C, while 70% were vaccinated after the MIS-C episode of their child. None of the children were vaccinated before the occurrence of the MIS-C, and only 9% (5/56) received the COVID-19 vaccine after the MIS-C. The predominant barriers to COVID-19 vaccination were concerns over potential side effects and insufficient support from their doctors. This emphasizes the crucial role of health care providers in promoting COVID-19 vaccination among children.
Collapse
Affiliation(s)
- Geraldine Blanchard-Rohner
- From the Division of General Pediatrics, Department of Child, Woman and Adolescent Medicine, Pediatric Immunology and Vaccinology Unit, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
| | - Carlos Sanchez
- Paediatric Research Centre, University Children’s Hospital Basel, University of Basel, Basel, Swizerland
| | - Maya C. Andre
- Division of Respiratory and Critical Care Medicine, University Children’s Hospital Basel, University of Basel, Basel, Switzerland
- Department of Pediatric Hematology and Oncology, University Children’s Hospital, Eberhard Karls University, Tuebingen, Germany
| | - Sabrina Bressieux-Degueldre
- Department of Women-Mother-Child, Paediatric Cardiology Unit, University Hospital of Lausanne and Lausanne University, Lausanne, Switzerland
| | - Serge Grazioli
- Division of Neonatal and Pediatric Intensive Care, Department of Child, Woman and Adolescent Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
| | - Marie-Helene Perez
- Department of Women-Mother-Child, Paediatric Intensive and Intermediate Care Units, University Hospital of Lausanne and Lausanne University, Lausanne, Switzerland
| | - Daniela Wütz
- Division of Pediatric Cardiology, Pediatric Heart Center, University Children’s Hospital Zurich, Zurich, Switzerland
| | - Nina Schöbi
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Tatjana Welzel
- Paediatric Research Centre, University Children’s Hospital Basel, University of Basel, Basel, Swizerland
- Division of Pediatric Rheumatology, University Children’s Hospital Basel, University of Basel, Basel, Switzerland
| | - Andrew Atkinson
- Paediatric Research Centre, University Children’s Hospital Basel, University of Basel, Basel, Swizerland
- Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, Missouri
| | - Luregn J. Schlapbach
- Department of Intensive Care and Neonatology, Children`s Research Center, University Children’s Hospital Zurich, Zurich, Switzerland
- Paediatric Intensive Care Unit, Child Health Research Centre, Queensland Children’s Hospital, The University of Queensland, Brisbane, Australia
| | - Julia A. Bielicki
- Centre for Neonatal and Paediatric Infection, St George’s University, London, United Kingdom
| | - Johannes Trück
- Divisions of Allergy and Immunology, Children’s Research Center, University Children’s Hospital Zurich, University of Zurich (UZH), Zurich, Switzerland
| |
Collapse
|